Alembic Global Holding incorporates wholly-owned subsidiary in USA
Vadodara: Alembic Global Holding SA, a wholly owned subsidiary of Alembic Pharmaceuticals Limited has incorporated a wholly-owned subsidiary in USA, named Alembic Lifesciences Inc.
Alembic Global Holding SA will be making a remittance to Alembic LifeSciences Inc. towards subscription of 100% shareholding.
"Alembic LifeSciences Inc. is incorporated in the State of Delaware, USA on 13th March, 2025 and is yet to commence its business operations," the Company stated in a BSE filing.
Medical Dialogues team had earlier reported that the Company had received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.
Read also: Alembic Pharma bags USFDA final approval for schizophrenia drug Brexpiprazole
Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.
